SCHEMBL20360396

SCHEMBL20360396

c1ccc(-c2cccc(-c3ccccc3)c2N2CCCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 2/20 0.46
RECQL P46063 2/20 0.46
PRKDC P78527 1/20 0.45
HTR7 P34969 2/20 0.44
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.44
HTR5A P47898 1/20 0.44
HTR6 P50406 1/20 0.44
MAP2K1 Q02750 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
EGFR P00533 1/20 0.42
RAF1 P04049 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20360705 0.98 PRKDC (0.48) ALDH1A1L3MBTL1KDM4ETDP1TSHR
Hydrochloric Acid SCHEMBL15329342 0.83 HTR7 (0.44) ALDH1A1KDM4ETDP1TSHRRECQL
SCHEMBL5487538 0.81 HTR7 (0.41) ALDH1A1L3MBTL1KDM4ETDP1TSHR
SCHEMBL5352962 0.78 HTR7 (0.69) ALDH1A1L3MBTL1KDM4ETDP1TSHR
SCHEMBL27876080 0.77 HTR7 (0.67) ALDH1A1L3MBTL1KDM4ETDP1TSHR
SCHEMBL13039956 0.77 HTR7 (0.67) ALDH1A1L3MBTL1KDM4ETDP1TSHR
Hydrochloric Acid SCHEMBL27892728 0.75 HTR7 (0.65) ALDH1A1L3MBTL1KDM4ETDP1TSHR
SCHEMBL18966914 0.72 HTR7 (0.51) ALDH1A1KDM4ETDP1HTR7HTR1A
SCHEMBL3953577 0.71 AR (0.47) ALDH1A1KDM4ETSHRPRKDCHTR2A
SCHEMBL18394614 0.71 MAPT (0.48) ALDH1A1L3MBTL1KDM4ETDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194775-A1 COMPOUND HAVING AGONISTIC ACTIVITY ON SOMATOSTATIN RECEPTOR, AND USE THEREOF FOR MEDICAL PURPOSES ONO PHARMACEUTICAL CO., LTD. (JP) 2018-07-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194775-A1 COMPOUND HAVING AGONISTIC ACTIVITY ON SOMATOSTATIN RECEPTOR, AND USE THEREOF FOR MEDICAL PURPOSES SSTR2, SSTR1, SSTR3 ALDH1A1 3249/4885L3MBTL1 1701/4885KDM4E 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.